Low Titer Anti-HBs: Implications for Hepatitis B Resistance

Low-titer hepatitis B antibodies, do they provide resistance against the hepatitis B virus?

Hello: Recently, during a health check, tests for HBsAg and Anti-HBs [5.13; <10(-), >10(+)] were both negative, so I went to the hospital to receive the hepatitis B vaccine, but I was unable to produce antibodies.
After testing for the core antibody Anti-HBc (IgG), the result was positive, indicating that the hepatitis B virus had previously entered my body and caused an infection.
I read some articles online suggesting that I might be a "low titer" carrier or have "low titer" antibodies.
Some healthy individuals who have been infected with the hepatitis B virus and produced antibodies may experience a decrease in antibody titer over time, sometimes resulting in undetectable levels.
Therefore, Anti-HBs can turn from positive to negative, leading to test results of HBsAg negative, Anti-HBs negative, and Anti-HBc positive.

(1) Can the core antibody Anti-HBc (IgG) positivity be increased through other methods? Is vaccination effective?
(2) Is there a way to enhance the antibodies produced after infection?
(3) Do these low titer antibodies, which are not vaccine-induced, provide resistance to the hepatitis B virus? Could they lead to a positive surface antigen result after close contact with a carrier, thus becoming a carrier themselves?
(4) What tests are needed to distinguish between a "low titer" carrier and "low titer" antibodies?

Mr. Wang, 30~39 year old female. Ask Date: 2018/03/26

Dr. Chen Shidian reply Gastroenterology and Hepatology

Hello, sir.
A blood serum test is sufficient.
Changhua Hospital cares about your health.
Chen Shidian.

Reply Date: 2018/03/26

More Info

Understanding low titer Anti-HBs and its implications for Hepatitis B resistance is crucial for managing and interpreting Hepatitis B virus (HBV) infections. In your case, the presence of Anti-HBc (IgG) indicates that you have been exposed to the virus at some point, but the absence of HBsAg and the inability to produce Anti-HBs after vaccination suggest a complex immunological response.

1. Can Anti-HBc (IgG) levels be increased through other methods? Is vaccination effective?
Anti-HBc (IgG) is a marker of past infection with HBV. Unfortunately, there is no specific treatment to increase the levels of Anti-HBc. Vaccination against Hepatitis B is designed to stimulate the production of Anti-HBs, which provides immunity against future infections. However, in your case, since you did not produce Anti-HBs after vaccination, it suggests that your immune system may not be responding adequately to the vaccine. This could be due to various factors, including age, underlying health conditions, or the presence of other immunological issues. In such cases, it may be beneficial to consult with a specialist in infectious diseases or a hepatologist for further evaluation and potential alternative vaccination strategies.

2. Is there a way to enhance the antibodies produced after infection?
Once the body has been exposed to HBV and has produced antibodies, the levels of these antibodies can wane over time. Unfortunately, there is no specific method to artificially boost these antibodies. However, maintaining a healthy lifestyle, including a balanced diet, regular exercise, and avoiding alcohol and hepatotoxic substances, can support your immune system. If you are concerned about your immunity, regular monitoring of your liver function and HBV markers is essential.

3. Do low titer antibodies provide any resistance to HBV?
Low titer antibodies, such as low levels of Anti-HBs, may not provide sufficient protection against HBV. The presence of Anti-HBc indicates past infection, but it does not guarantee immunity. If you have low or undetectable levels of Anti-HBs, you may still be at risk of re-infection, especially if you come into contact with an active HBV carrier. Close contact with an HBV carrier can potentially lead to the reactivation of the virus, especially if your immune system is compromised.

4. What tests can differentiate between low titer carriers and low titer antibodies?
To distinguish between a low titer carrier and someone with low titer antibodies, a comprehensive serological profile is necessary. This typically includes:
- HBsAg: To check for active infection.

- Anti-HBs: To assess immunity status.

- Anti-HBc (IgG and IgM): To determine past or acute infection.

- HBV DNA testing: To measure the viral load, which can indicate active replication of the virus.

- Liver function tests: To evaluate liver health and function.

In conclusion, your situation highlights the complexity of HBV immunology. While the presence of Anti-HBc (IgG) indicates a past infection, the inability to produce Anti-HBs after vaccination raises concerns about your immune response. Regular monitoring and consultation with healthcare professionals specializing in liver diseases are essential for managing your health effectively. If you have further questions or concerns, do not hesitate to reach out to your healthcare provider for personalized advice and management strategies.

Similar Q&A

Understanding Drug Resistance in Hepatitis B Treatment: Key Insights and Concerns

1. The doctor mentioned there are two methods: one is to add liver function support, or switch to the latest hepatitis B medication (entecavir, brand name: Viread). 2. I would like to ask, since I have been taking medication since 2003 and my HBeAg has always been positive, does...

Dr. Chen Qifeng reply Gastroenterology and Hepatology
Hello: The biggest challenge in the treatment of hepatitis B is drug resistance. So far, Tenofovir and Entecavir are considered to have low resistance rates. In the case of Entecavir, there has been no evidence of drug resistance in the five-year studies conducted to date. Additi...

Understanding Anti-HBs Levels and Their Implications for Liver Health

Hello, doctor. Could you please explain what a positive Anti-HBs value of + (108.22) indicates? Additionally, I have a mild fatty liver observed during an abdominal ultrasound. Thank you.

Dr. Chen Shidian reply Gastroenterology and Hepatology
Hello, Miss. The concentration of hepatitis B antibodies is a concern for your health at Changhua Hospital. Chen Shidian.

Can Hepatitis B Surface Antigen Become Negative with Treatment?

Hello, I am a carrier of hepatitis B. Recently, my surface antigen decreased from 1.3 to 1.04, while my surface antibody levels are between 5.6 and 5.56. In previous years, my surface antigen was consistently above 5 or higher. Is there any active treatment available that can hel...

Dr. Lin Minghui reply Gastroenterology and Hepatology
Hello, 1. For the treatment of hepatitis B, there are currently five antiviral medications and interferons (both long-acting and short-acting). Antiviral medications reduce HBV-DNA and improve liver function. Interferons have immunomodulatory and antiviral properties. Other mec...

Understanding HBV Resistance: A Case Study in Treatment Challenges

My son is 24 years old and studying for his master's degree in America. He is HBe positive and has a negative HBe antigen. He has been on lamivudine since January 2008. On December 29, 2008, his lab results showed AST 31, ALT 46, and HBV-DNA approximately 500 million copies/...

Dr. Chen Shidian reply Gastroenterology and Hepatology
Hello Mr. John: You may first check for HBV drug resistance (out-of-pocket, available only at a few medical centers). If drug resistance is present, you may consider switching medications (though there is a risk of developing resistance again) or, depending on the situation, swit...